{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:20:12Z","timestamp":1793110812220,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbr.2023.114674","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T11:48:42Z","timestamp":1694864922000},"page":"114674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats"],"prefix":"10.1016","volume":"455","author":[{"given":"Hannah L.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2023.114674_bib1","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2023.114674_bib2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.euroneuro.2016.09.003","article-title":"Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats","volume":"26","author":"Boekhoudt","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114674_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-019-12236-z","article-title":"High-potency ligands for DREADD imaging and activation in rodents and monkeys","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2023.114674_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s11011-019-00442-z","article-title":"Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice","volume":"34","author":"Jing","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2023.114674_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1523\/JNEUROSCI.0537-18.2018","article-title":"Chemogenetic manipulations of ventral tegmental area dopamine neurons reveal multifaceted roles in cocaine abuse","volume":"39","author":"Mahler","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114674_bib6","article-title":"The chemogenetic receptor ligand clozapine N-oxide induces in vivo neuroreceptor occupancy and reduces striatal glutamate levels","volume":"0","author":"B\u00e6rentzen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2023.114674_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aan2475","article-title":"Chemogenetics revealed: DREADD occupancy and activation via converted clozapine","volume":"357","author":"Gomez","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbr.2023.114674_bib8","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0219-16.2016","article-title":"Clozapine N-oxide administration produces behavioral effects in long-evans rats: Implications for designing DREADD experiments","volume":"3","author":"MacLaren","year":"2016","journal-title":"ENeuro"},{"key":"10.1016\/j.bbr.2023.114674_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41593-020-0661-3","article-title":"Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys","volume":"23","author":"Nagai","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2023.114674_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1567","article-title":"Olanzapine: a potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics","volume":"5","author":"Weston","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbr.2023.114674_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acsptsci.8b00012","article-title":"DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo","volume":"1","author":"Thompson","year":"2018","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bbr.2023.114674_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-9065-8_4","article-title":"Practical considerations for the use of DREADD and other chemogenetic receptors to regulate neuronal activity in the mammalian brain","volume":"1937","author":"Aldrin-Kirk","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbr.2023.114674_bib13","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0171-19.2019","article-title":"DREADDs: the power of the lock, the weakness of the key favoring the pursuit of specific conditions rather than specific ligands","volume":"6","author":"Goutaudier","year":"2019","journal-title":"ENeuro"},{"key":"10.1016\/j.bbr.2023.114674_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(98)00020-7","article-title":"d-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats","volume":"23","author":"Antoniou","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2023.114674_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00421062","article-title":"Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat","volume":"41","author":"Pijnenburg","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.bbr.2023.114674_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-022-06068-x","article-title":"Increased elasticity of sucrose demand during hyperdopaminergic states in rats","author":"Minnaard","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2023.114674_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-10668-0","article-title":"Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats","volume":"12","author":"Nentwig","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2023.114674_bib18","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0345-17.2018","article-title":"Locomotor-and reward-enhancing effects of cocaine are differentially regulated by chemogenetic stimulation of Gi-signaling in dopaminergic neurons","volume":"5","author":"Runegaard","year":"2018","journal-title":"ENeuro"},{"key":"10.1016\/j.bbr.2023.114674_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238156","article-title":"Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats","volume":"15","author":"Goutaudier","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2023.114674_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00173","article-title":"Behavioral effects of acute systemic low-dose clozapine in wild-type rats: implications for the use of DREADDs in behavioral neuroscience","volume":"12","author":"Ilg","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2023.114674_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2022.03.028","article-title":"CNO administration increases dopamine and glutamate in the medial prefrontal cortex of wistar rats: Further concerns for the validity of the CNO-activated DREADD procedure","author":"Rodd","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114674_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2007.03.014","article-title":"Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration","volume":"87","author":"Swerdlow","year":"2007","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.bbr.2023.114674_bib23","article-title":"A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition","author":"Lawson","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114674_bib24","doi-asserted-by":"crossref","unstructured":"Goossens M.-G., Larsen L.E., Vergaelen M., Wadman W., Van Den Haute C., Brackx W., et al. Level of hM4D(Gi) DREADD Expression Determines Inhibitory and Neurotoxic Effects in the Hippocampus 2021. https:\/\/doi.org\/10.1523\/ENEURO.0105\u201321.2021.","DOI":"10.1523\/ENEURO.0105-21.2021"},{"key":"10.1016\/j.bbr.2023.114674_bib25","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1523\/JNEUROSCI.1422-18.2018","article-title":"Behavioral effect of chemogenetic inhibition is directly related to receptor transduction levels in rhesus monkeys","volume":"38","author":"Upright","year":"2018","journal-title":"J. Neurosci."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:41:24Z","timestamp":1759066884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":25,"alternative-id":["S0166432823003923"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114674","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114674"}}